Innovative Medicines Venture Meeting

Melanie Aregger
InSphero AG

Melanie Aregger

Head of BU InSphero Diagnostics
InSphero AG (Switzerland)
Life Sciences
Dragos Cirneci
Dragos Cirneci

Dragos Cirneci

Neuroscientist
Neurorad (Romania)
Life Sciences
Nathalie Compagnone
Nathalie Compagnone

Nathalie Compagnone

CEO
ICDD (France)
Life Sciences
Hans Constandt
ONTOFORCE

Hans Constandt

CEO & Founder
ONTOFORCE (Belgium)
ICT
Aidan Courtney
Aidan Courtney

Aidan Courtney

Chief Executive Officer
Roslin Cells Ltd (United Kingdom)
Life Sciences
Daniela Couto
Cell2B

Daniela Couto

Founding CEO
Cell2B (Portugal)
Life Sciences
Eduardo Gonzalez-Couto
Integromics, S.L.

Eduardo Gonzalez-Couto

Chief Strategic Officer
Integromics, S.L. (Spain)
ICT
Michael Hamacher
Lead Discovery Center GmbH

Michael Hamacher

Head of Finance & Administration
Lead Discovery Center GmbH (Germany)
Life Sciences
Tamas Letoha
Pharmacoidea Ltd.

Tamas Letoha

Chief Executive Officer
Pharmacoidea Ltd. (Hungary)
Life Sciences
Jordi Mestres
Jordi Mestres

Jordi Mestres

President
Chemotargets SL (Spain)
Life Sciences
Roger Rosedale
Roger Rosedale

Roger Rosedale

CEO
Microsens Biotechnology (United Kingdom)
Life Sciences
Ted Roverts
Mercachem B.V

Ted Roverts

Financial Controller
Mercachem B.V (Netherlands)
Life Sciences
Timo Vaara
Timo Vaara

Timo Vaara

VP, Business Development
Northern Antibiotics Ltd (Finland)
Life Sciences
Anne-Fabienne Weitsch
Anne-Fabienne Weitsch

Anne-Fabienne Weitsch

CEO
ENDOCELLS (France)
Life Sciences